Tivic Health Systems, Inc. Stock

Equities

TIVC

US8887052095

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 04:00:00 2024-05-28 pm EDT 5-day change 1st Jan Change
0.4097 USD +1.19% Intraday chart for Tivic Health Systems, Inc. -10.88% -77.24%
Sales 2022 1.84M Sales 2023 1.18M Capitalization 2.64M
Net income 2022 -10M Net income 2023 -8M EV / Sales 2022 1.74 x
Net cash position 2022 2.99M Net cash position 2023 3.03M EV / Sales 2023 -0.33 x
P/E ratio 2022
-0.61 x
P/E ratio 2023
-0.17 x
Employees 9
Yield 2022 *
-
Yield 2023
-
Free-Float 99.66%
More Fundamentals * Assessed data
Dynamic Chart
Earnings Flash (TIVC) TIVIC HEALTH SYSTEMS Reports Q1 Revenue $334,000 MT
Tivic Health Systems, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Transcript : Tivic Health Systems, Inc., Q1 2024 Earnings Call, May 15, 2024
Tivic Health Announces Successful Completion of Non-Invasive Vagus Nerve Stimulation Study; Demonstrates Clinically Effective Biological Changes in the Autonomic, Cardiac, and Central Nervous Systems CI
Transcript : Tivic Health Systems, Inc., 2023 Earnings Call, Mar 25, 2024
Tivic Health Systems, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Tivic Health Announces Completion of Enrollment for Study of Novel Non-Invasive Bioelectronic Approach to Vagus Nerve Stimulation CI
Tivic Health®? Systems, Inc. Enters Exclusive Distribution Agreement with Top 10 Medical Product Distributor for Mass Market Retail CI
Tivic Health Systems, Inc. Announces Termination of Ryan Sabia as Chief Operating Officer CI
Tivic Health Systems, Inc. Announces Launch of Second Generation of Tivic ClearUP CI
Top Premarket Decliners MT
Tivic Health Systems Seeks M&A CI
Transcript : Tivic Health Systems, Inc., Q3 2023 Earnings Call, Nov 14, 2023
Earnings Flash (TIVC) TIVIC HEALTH SYSTEMS Posts Q3 Revenue $282,000 MT
Tivic Health Systems, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
More news
1 day+1.19%
1 week-14.65%
Current month-60.61%
1 month-60.61%
3 months-66.42%
6 months-82.19%
Current year-77.24%
More quotes
1 week
0.35
Extreme 0.3485
0.47
1 month
0.35
Extreme 0.3485
1.85
Current year
0.35
Extreme 0.3485
2.24
1 year
0.35
Extreme 0.3485
21.75
3 years
0.35
Extreme 0.3485
650.00
5 years
0.35
Extreme 0.3485
650.00
10 years
0.35
Extreme 0.3485
650.00
More quotes
Managers TitleAgeSince
Founder 56 16-09-21
Director of Finance/CFO 52 23-04-27
Chief Tech/Sci/R&D Officer 40 19-02-28
Members of the board TitleAgeSince
Chairman 77 19-07-15
Director/Board Member 64 19-07-15
Founder 56 16-09-21
More insiders
Date Price Change Volume
24-05-28 0.4097 +1.19% 157,972
24-05-24 0.4049 -1.24% 215,830
24-05-23 0.41 -10.85% 397,965
24-05-22 0.4599 +0.04% 578,026
24-05-21 0.4597 -4.23% 385,941

Delayed Quote Nasdaq, May 28, 2024 at 04:00 pm EDT

More quotes
Tivic Health Systems, Inc. is a commercial-stage health tech company advancing the field of bioelectronic medicine. The Company’s patented technology platform leverages stimulation on the trigeminal, sympathetic, and vagus nerve structures. Its non-invasive and targeted approach to the treatment of inflammatory chronic health conditions is intended to give consumers and providers drug-free therapeutic solutions with high safety profiles, low risk, and broad applications. The Company’s first commercial product, ClearUP, is an FDA approved handheld bioelectronic sinus device. ClearUP is clinically proven, doctor-recommended, and available through online retailers and commercial distributors. ClearUP is sold in the U.S. directly to consumers on various platforms and through reseller channels. The Company is also focused on its intellectual property (IP) portfolio and research programs related to vagus nerve stimulation to expand its applications in non-invasive bioelectronic medicine.
More about the company

Quarterly revenue - Rate of surprise